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Abstract  29 
Laminitis is a common debilitating disease in horses that involves painful disruption of the 30 
lamellar dermo-epidermal junction within the hoof. This condition is often refractory to 31 
conventional anti-inflammatory analgesia and results in unremitting pain, which in severe 32 
cases requires euthanasia.  The mechanisms underlying pain in laminitis were investigated 33 
using quantification of behavioural pain indicators in conjunction with histological studies of 34 
peripheral nerves innervating the hoof. Laminitic horses displayed consistently altered or 35 
abnormal behaviours such as increased forelimb lifting and an increased proportion of time 36 
spent at the back of the box compared to normal horses. Electron micrographic analysis of the 37 
digital nerve of laminitic horses showed peripheral nerve morphology to be abnormal, as well 38 
as having reduced numbers of unmyelinated (43.2%) and myelinated fibers (34.6%) 39 
compared to normal horses. Sensory nerve cell bodies innervating the hoof, in cervical, C8 40 
dorsal root ganglia (DRG), showed an upregulated expression of the neuronal injury marker, 41 
activating transcription factor-3 (ATF3) in both large NF-200-immunopositive neurons and 42 
small neurons that were either peripherin- or IB4-positive. A significantly increased 43 
expression of neuropeptide Y (NPY) was also observed in myelinated afferent neurons. These 44 
changes are similar to those reported in other neuropathic pain states and were not observed in 45 
the C4 DRG of laminitic horses, which is not associated with innervation of the forelimb. 46 
This study provides novel evidence for a neuropathic component to the chronic pain state 47 
associated with equine laminitis, indicating that anti-neuropathic analgesic treatment may 48 
well have a role in the management of this condition. 49 
 50 
Keywords: Neuropathic pain, Dorsal root ganglion, Equine laminitis, neuronal injury marker, 51 
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 53 
 54 
 55 
 56 
1. Introduction  57 
Laminitis is a common cause of equine lameness involving one or more feet (Dyson, 2003). It 58 
is characterised by disruption of the dermo-epidermal laminar bond within the hoof (Fig. 1b, 59 
c) and subsequent structural weakness that can result in displacement of the pedal bone within 60 
the hoof capsule (Pollitt et al., 1998). The pathogenesis of this disease is poorly understood 61 
but it is generally thought that vascular disturbances leading to ischemia-reperfusion injury of 62 
the lamellar structures are involved in the pathophysiology of laminitis (Hood, 1999). 63 
Currently, no therapeutic regime is able to arrest or prevent its onset (Pollitt, 2003). 64 
Moreover, laminitic pain can be difficult to control using traditional anti-inflammatory agents 65 
and euthanasia on welfare grounds is not uncommon (Herthel and Hood, 1999; Swanson, 66 
1999; Pollitt, 2003). Therefore, improved understanding of laminitis is much needed.  67 
We hypothesized that the pathological inflammatory processes affecting the hoof laminae 68 
during laminitis also damage the sensory neurons innervating this region. Peripheral nerve 69 
injury can be associated with the generation of a neuropathic pain state characterised by 70 
allodynia (the perception of normally innocuous stimuli as painful), hyperalgesia (a 71 
heightened response to painful stimuli), spontaneous pain and a lack of response to 72 
conventional analgesics. A key factor in the neural plasticity underlying neuropathic 73 
(compared to inflammatory) pain is altered gene expression in sensory DRG neurons (Hökfelt 74 
et al., 1994; Cummins et al., 2000; Woolf and Salter, 2000; Xiao et al., 2002). This can be 75 
demonstrated by an increase in expression of the neuronal injury marker ATF3, a member of 76 
the activating transcription factor/cAMP-responsive element binding protein (ATF/CREB) 77 
family, in sensory DRG cells (Hai et al., 1999; Tsujino et al., 2000). Furthermore, phenotypic 78 
changes occur in primary afferent DRG neurons after peripheral nerve damage, resulting in 79 
altered expression of neuropeptides, including neuropeptide Y (NPY), the expression of 80 
which is induced from normally low levels in large diameter, neurofilament-200 (NF-200)-81 
positive neurons following axotomy (Wakisaka et al., 1991; Hokfelt et al., 1994), nerve injury 82 
(Ma and Bisby, 1998; Munglani et al., 1995), demyelination (Wallace et al., 2003) and 83 
streptozotocin-induced diabetes (Rittenhouse et al., 1996). 84 
Injury to sensory nerves induces neurochemical, physiological and anatomical modifications 85 
to afferent and central neurons that are likely to contribute to chronic, sensitised neuropathic 86 
pain responses (Woolf and Salter, 2000). Such changes to the sensory neurons innervating the 87 
equine foot could lead to a clinically relevant component of chronic pain as it would explain 88 
the limited effectiveness of conventional analgesics in the treatment of laminitic pain (Herthel 89 
and Hood, 1999). 90 
Therefore, the aims of this study were to identify and quantify equine laminitic pain using 91 
objective behavioural assessment, characterise peripheral nerve damage in the lateral digital 92 
nerve and demonstrate potential nerve injury-associated alterations in protein expression in 93 
DRG sensory neurons innervating the feet of horses with laminitis.  94 
 95 
2. Methods  96 
 97 
2.1. Behavioural  observations in laminitic and clinically normal horses 98 
In order to define and quantify the behavioural characteristics of equine laminitis, we carried 99 
out continuous video monitoring over 3 days to compare behaviours in laminitic and normal 100 
horses. 101 
Seven horses admitted for management of refractory laminitis were selected using the 102 
following clinical criteria: animals must have displayed clinical signs consistent with this 103 
disease including multi-limb lameness, increased amplitude of the digital pulses, warmth 104 
across the dorsal hoof wall and a laminitic gait (Stashak, 2002). For details of all laminitic 105 
horses used in this study see Table 1. 106 
Latero-medial radiographs of the fore limb digits were obtained from each of these horses 107 
(Butler et al, 2000). The position of the pedal bone within the hoof capsule was evaluated 108 
both subjectively and objectively by an experienced equine clinician using standard measures 109 
(Fig.1a).  110 
 111 
Informed client consent was obtained in writing prior to the onset of data collection. 112 
Laminitic horses received phenylbutazone (PBZ) twice daily at 08:00h and 20:00h 113 
(Equipalazone Arnolds, UK; 2.2-4.0 mg.kg-1) and intramuscular acepromazine three times 114 
daily at 08:00h, 16:00h and 24:00h (ACP Novartis, UK; 0.02-0.04 mg.kg-1). On the day of 115 
admission to hospital the timing of drug administration varied between individuals. Pedal 116 
bone support (Styrofoam Solar Support System™/Lilypads™) was provided at the clinician’s 117 
discretion. Subjects participated in the study for a maximum of 3 days. Seven age, type and 118 
sex-matched horses, which were considered ‘pain free’ (control group) were stabled directly 119 
opposite the laminitic horses and recorded simultaneously in order to account for extraneous 120 
effects on behaviour. All horses were maintained on shavings and had free access to water. 121 
Laminitic animals were fed restricted rations of soaked hay, as is standard procedure, whereas 122 
control animals received haylage ad libitum.  123 
24-hour time-lapse video equipment (AG-6124, Panasonic) was used to record undisturbed 124 
behaviour in each stable. Point samples of 1 hour duration were taken at 8 hour-intervals, at 125 
06:00h, 14:00h and 22:00h, during 3 days starting at 14.00h on Day 1. Samples were analysed 126 
continuously for duration of state and frequency of event behaviour (The Observer™ vs. 4.1, 127 
Noldus Information Technology, The Netherlands).  128 
Two behaviours were selected for statistical analysis as being representative of the behaviours 129 
where changes were most likely to be observed (Price et al., 2003; Reitmann et al., 2004). 130 
Frequency of ‘forelimb lifting’ (as lifts min-1) was defined as the raising and lowering of a 131 
forelimb, without locomotion and was adjusted for total time spent standing. ‘Proportion of 132 
time spent at the back of the box’ was defined as time spent positioned in the furthest 50% of 133 
the box, away from the entrance to the stable.   134 
On a repeated dose regime, peak PBZ concentrations occur between 2 and 6 hours following 135 
administration, although individual variation is high (Gerring et al., 1981). In the present 136 
study a 12-hour dosing regime was used, minimising variation and increasing the probability 137 
of the maintenance of a ‘steady state’. For sample point analysis of behaviours, data were 138 
collected at three different time points to reflect an expected minimum plasma PBZ 139 
concentration (06:00h) and shortest (2 hours post-administration – 22:00h) and longest (6 140 
hours post administration – 14:00h) times for peak PBZ concentrations were chosen. In 141 
addition, to evaluate some of the possible effects of drug accumulation, analyses were 142 
repeated just using data from day 1, days 1 and 2 and days 1, 2 and 3.   143 
 144 
2.2. Morphological investigations  145 
 Lateral digital nerves were obtained from five horses euthanised on clinical grounds due to 146 
laminitis which was either recurrent or refractory to therapy and also from four horses which 147 
had no history of forelimb lameness that were euthanised for clinical reasons other than 148 
forelimb pathology (control group). The lateral digital nerves were removed from the 149 
forelimb (3 cm long segments) at the level of the proximal sesamoid bone and fixed for 4 150 
hours in 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium cacodylate buffer, 151 
pH 7.3, post-fixed in OsO4, and embedded in Araldite. For light microscopy, 1 µm resin 152 
sections of the nerve were stained with Toluidine blue and three fascicles were chosen at 153 
random by bright-field microscopy. Ultra-thin (80 nm) sections were stained with uranyl 154 
acetate and lead citrate and examined on a Phillips BioTwin electron microscope (FEI, UK 155 
Ltd, Cambridge, UK).  Electron microscope (EM) images of cross sections of fascicles within 156 
each nerve (areas ranging between 6732 and 47215 µm2) were analysed by eye by a trained, 157 
blinded observer using Image Tool 3.0 (UTHSCSA, USA). The total area of the nerve 158 
sections and the percentage of the nerve area occupied by nerve fascicles were calculated in 159 
order to investigate any differences between normal and laminitic digital nerves that might 160 
reflect oedema and therefore affect the quantification of axon density. The number and axon 161 
diameter of intact myelinated fibers was calculated as well as the percentage of damaged 162 
myelinated fibers, defined as those with a severe disruption of the myelin sheath and/or 163 
axonal degeneration. Myelin sheath thickness was measured and G-ratio of axons was 164 
calculated by dividing the axonal diameter by the total diameter of axon plus myelin sheath. 165 
The proportion of A-fibers with continuous Schwann cell cytoplasm (an abnormal 166 
morphological feature previously described by Court et al., 2004) was also determined. C-167 
fibers were identified as small-diameter unmyelinated fibers, surrounded by Schwann cell 168 
cytoplasm. The total number of C-fibers was calculated as well as the percentage of solitary 169 
unmyelinated fibers and the number of unmyelinated fibers per Remak bundle. All analysis 170 
was carried out on identity-concealed samples.   171 
 172 
2.3. Immunohistochemistry 173 
DRG from cervical segments 8 (forelimb innervation) and 4 (non-forelimb innervation) from 174 
the same horse were obtained post-mortem from the five laminitic horses and four control 175 
horses. The tissue was snap frozen and embedded in OCT embedding matrix (Cell Path plc. 176 
Powys. Wales, UK). Cryostat sections of C8 DRGs (15 µm) were thaw-mounted on poly-L-177 
lysine slides (Merck-BDH).   178 
DRG sections were pre-incubated for 1h at room temperature in 0.1 M PBS, pH 7.4, buffer 179 
containing 0.2% Triton X-100, 2% fish skin gelatin and 10% normal goat serum; and then 180 
incubated overnight at 4 °C with primary antibodies diluted in the same buffer. For co-181 
localisation of the peptide NPY or ATF3 with the myelinated cell marker neurofilament 200 182 
kDa (NF-200) (Lawson and Waddell, 1991; Michael et al., 1999), or either of the 183 
unmyelinated cell markers, peripherin or isolectin B4 (IB4) (Goldstein et al., 1991; Michael 184 
and Priestley, 1999), antisera/lectin were used at the following concentrations: rabbit anti-185 
NPY (1:250; Peninsula Laboratories Inc, Belmont, CA, USA); rabbit anti-ATF3 (1:300; 186 
Santa Cruz Biotechnology, Santa Cruz, CA, USA); mouse monoclonal anti-NF-200 (1:400; 187 
clone N52; Sigma); mouse monoclonal anti-peripherin (1:250; Chemicon International, 188 
Harlow, UK); IB4 from Bandeiraea simplicifolia (1:400; Sigma). Sections were then washed 189 
in buffer and incubated at room temperature for 2 hours with Alexafluor 488-labeled goat 190 
anti-mouse IgG (1:500; Molecular Probes Europe BV, The Netherlands), Alexafluor 568-191 
labeled goat anti-rabbit IgG (1:1000; Molecular Probes Europe BV, The Netherlands) or 192 
Alexa Fluor 488–labeled streptavidin (1:200). Three washes in 0.1M PBS were performed 193 
before the addition of To-Pro3 cyanine nucleic acid stain (Molecular Probes Europe BV, The 194 
Netherlands). Three final washes in 0.1 M PBS were conducted before cover-slipping with 195 
Vecta-Shield (Vector Laboratories, Burlingame, CA, USA).  Control sections were processed 196 
as above omitting the primary reagents.   197 
Observations were made and sections photographed on an Olympus microscope equipped for 198 
epifluorescence. All counts of profiles labelled for immunopositive cells were performed by 199 
the same observer (who was blinded to sample treatment) on randomly selected, 15 µm 200 
sections of DRG from each of the animals in each group.  Every sixth section was selected to 201 
ensure that measurements were taken only once for each cell.  Results were expressed as the 202 
proportion of labelled profiles per total number of single or double-labelled profiles from all 203 
sections, 95% confidence intervals (CI) are indicated.   204 
 205 
2.4. Western blots 206 
C4 and C8 DRG were taken from laminitic horses (n=3). Whole lysate preparations were 207 
prepared by homogenising tissue in 20 volumes of Laemmli lysis buffer (Tris (tris-208 
hydroxymethylaminoethane, 50 mM, pH 7.4), 5% mercaptoethanol and 2% sodium dodecyl 209 
sulphate (SDS)), boiled for 5 min and frozen. Western blotting was carried out as described 210 
previously (Garry et al., 2005). Blots were incubated with rabbit polyclonal primary 211 
antibodies to ATF3 (1:200 Santa Cruz Biotechnology, Santa Cruz, CA, USA) and detected by 212 
peroxidase-linked secondary antibody and enhanced chemiluminescence. The ubiquitous 213 
housekeeping enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 1:750, 214 
Chemicon) was monitored as a control for protein level normalisation. Quantitative 215 
densitometry analysis of protein bands was performed using the ScanAnalysis (Elsevier) 216 
program. 217 
 218 
2.5 Statistical analyses  219 
Linear mixed-effect models were used to determine any differences between laminitic and 220 
controls horses in the frequency of lifting the forelimb and time spent at the back of the box, 221 
in order to account for the repeated sampling of the same horses (Pinheiro and Bates, 2000). 222 
The ID of the horse that the samples came from was entered as a random effect. 223 
Laminitic/control, time point in experiment and time of day were entered as fixed effects. 224 
Prior to analysis of the forelimb lifting results, the data were square root-transformed to 225 
achieve normalisation of the residuals.   226 
For the analysis of percentages of damaged A-fibers, A-fibers with Schwann cell cytoplasm 227 
and solitary unmyelinated fibers, only one meaned value per horse was obtained, and 228 
therefore repeated sampling has not taken place. Repeated measures of mean axon diameters 229 
in myelinated and unmyelinated fibers and thickness of myelin sheath were taken in both 230 
control and laminitic horses. Therefore, linear-mixed effect models were also used to 231 
determine any differences between (i) mean axon diameters in myelinated and unmyelinated 232 
fibers; (ii) thickness of myelin sheath from laminitic and control horses. Multiple 233 
measurements per horse were also taken of the number of fibers per Remak bundle but as the 234 
data were integers, differences in the number of fibers per Remak bundle were analysed using 235 
generalised linear mixed-effect models with Poisson errors. Only a single measurement per 236 
horse of the percentage of damaged A fibers; A fibers with continuous Schwann cell 237 
cytoplasm and solitary unmyelinated fibers were taken, therefore simple logistic regressions 238 
were employed to determine the differences between control and laminitic horses.  239 
Differences in total nerve area occupied by fascicles between normal and laminitic horses 240 
were investigated using a Student’s t-test, and differences in the percentage of nerve area 241 
occupied by fascicles between normal and laminitic horses by general linear models with 242 
binomial errors. Any differences in the proportion of labelled profiles were assessed by χ2 243 
analysis. Mann-Whitney non-parametric tests were used to analyse fiber density.  Immunoblot 244 
data were analysed using a matched pair t-test. All analyses were carried out in S-PLUS 6.0 245 
(Insightful, Seattle, USA) and SigmaStat 2.03 (SPSS Inc., USA). In all cases p<0.05 was 246 
taken to indicate statistical significance, and degrees of freedom associated with any tests are 247 
denoted by subscripts. 248 
 249 
3. Results  250 
 251 
3.1. Radiographic abnormalities associated with laminitis were seen in all the laminitic 252 
horses. 253 
The horses clinically diagnosed with laminitis displayed radiographic evidence of this disease 254 
when the radiographs were evaluated objectively (Butler et al., 2000). The angle between the 255 
dorsal hoof wall and the dorsal surface of the distal phalanx was increased when compared to 256 
normal values (Fig 1a). The mean (± SD) values from the laminitic group were 8.2º ±3.0º 257 
(normal values -0.86º ± 2.4º) (Cripps and Eustace, 1999).  Assessment of the D distance 258 
between the extensor process of the distal phalanx and the coronary band also showed a 259 
marked increase in the laminitic group (D= 16.4mm ±4.9mm) when compared to normal 260 
values (4.1mm ± 2.17mm) (Cripps and Eustace, 1999). Histological sections of laminitic 261 
tissue also indicated inflammatory changes (Fig. 1d ). 262 
 263 
3.2. Laminitic horses display quantifiable abnormal behaviours  264 
3.2.1. Data Analysis: Forelimb lifting  265 
When considering overall data, laminitic horses show a statistically significant increase in the 266 
mean square root frequency of forelimb lifting (F1,12=11.5, p=0.005; Fig. 2a) adjusted for time 267 
spent standing compared to control horses recorded in the same environment over the same 268 
time period. Fluctuations in the frequency of this behaviour occurred in both groups over the 269 
period of observation, but the pattern of such changes did not differ significantly between 270 
control and laminitic horses (F1,140=3.6, p=0.059).  271 
3.2.2. Data analysis proportion of time spent at the back of the box 272 
Laminitic horses spent significantly more time at the back of the box than control horses 273 
(F1,12=6.1, p=0.03). There was no difference between the 2 groups in how behaviour altered 274 
throughout the study (F1,148=0.2, p=0.683) (Fig. 2b). Time spent at the back of the box was 275 
markedly higher in laminitics than in controls at both 06:00h and 22:00h but not at 14:00h 276 
(days 2 & 3), when assessing individual sample point data. This effect is not seen at 14:00h 277 
on day one, probably because drug administration regimes were not well-established at this 278 
time. 279 
 280 
3.3. Distinct morphological abnormalities in both myelinated and unmyelinated 281 
peripheral nerve fibers innervating the hoof, in the lateral digital nerve of laminitic 282 
horses.  283 
The lateral digital nerves at the level of the proximal sesamoid bone were examined from both 284 
normal and laminitic horses. A mean of 11.65% (range 8.75-14.35) of the total fascicle area 285 
from each nerve section was analysed. EM analysis of three randomly selected fascicles per 286 
lateral digital nerve revealed morphological differences in both the myelinated and 287 
unmyelinated fiber populations in laminitic compared to non-laminitic horses (Table 2). 288 
Abnormalities in the shape of surviving axons and disruption of the myelin sheath, with 289 
accumulation of lipid droplets and myelin debris were observed.  The most obvious 290 
quantitative feature appeared to be a significant reduction in the number of both unmyelinated 291 
(-43.2%) and myelinated fibers (-34.6%) per unit area in laminitic compared to control horses 292 
(p=0.016). In order to eliminate the possibility that any nerve oedema could artefactually lead 293 
to the appearance of reduced fiber density, morphometric analyses were carried out to 294 
measure the percentage area of nerve sections occupied by fascicles and total nerve area in 295 
normal compared to laminitic horses. No significant differences in the mean percentages were 296 
identified (t4=-0.91, p= 0.414) between normals 37% (95% CI: 35.7-38.1) and laminitics 41% 297 
(39.5-42.0). No significant differences in total nerve area were identified between normal and 298 
laminitic horses (t4=-0.43, p=0.692). Further abnormalities were a significant decrease in the 299 
number of unmyelinated nerve fibers per Remak bundle (F1,7 =20.7, p=0.003) together with an 300 
increase in the percentage of solitary unmyelinated fibers in laminitics compared to normal 301 
horses (χ21= 35.7, p<0.001, Fig. 3; Table 2b). The percentage of morphologically damaged 302 
myelinated fibers was significantly higher in laminitic horses when compared to normal 303 
horses (χ21= 31.5, p<0.001, Fig. 3; Table 2 a). Finally, the proportion of myelinated fibers 304 
with continuous Schwann cell cytoplasm was significantly higher in the laminitic horses 305 
(χ2=338.4, p<0.001). No significant differences in myelin thickness or G-ratios were 306 
identified in laminitic compared to normal horses (F1,7 <0.5, p>0.311).  307 
 308 
3.4. The neuronal injury marker ATF3 is selectively expressed in sensory neurons 309 
innervating the forelimb in laminitic horses. 310 
Using immunohistochemical analysis of the DRG cell population, we assessed the presence 311 
of ATF3 in comparison with the expression of NF-200 and either IB4 or peripherin. ATF3 312 
expression was significantly increased in NF-200-positive C8 DRG cells from laminitic 313 
horses (n=3), where 67% (15 sections, 304 cells, CI  58.8-69.9) of NF-200-positive DRG 314 
cells co-expressed ATF3, while only 10% (15 sections, 345 cells, CI  6.9-13.5) of NF-200-315 
positive DRG cells in control horses (n=3) co-localised ATF3 (χ21=208, p<0.001), (Fig. 4). 316 
There was a significantly increased expression of ATF3 in IB4-positive C8 DRG cells in 317 
laminitic horses (n=3), where 54% (5 sections, 53 cells, CI 41.5-67.3) of IB4-positive C8 318 
DRG cells co-localised ATF3 compared with 9% ( 5 sections 56 cells, CI 3.9-19.3) in control 319 
horses (n=3) (χ21 = 24.5, p<0.001). There was also a significantly increased proportion of 320 
peripherin-positive DRG cells that were positive for ATF3 in C8 DRG cells from laminitic 321 
horses, (n=3), where 57% (9 sections, 115 cells, CI 47.6-65.4) of peripherin-positive cells co-322 
expressed ATF3 compared with 21% (9 sections, 127 cells CI 13.8-29.4) showing double-323 
labelling in control horses (n=3) (χ21  = 30.9, p=0.001; Fig. 4).  324 
Accordingly, immunoblot analysis revealed a significant increase (p<0.05) in ATF3 325 
expression (expressed as mean percentage of GAPDH expression) in C8 DRG (38.9% (28.7-326 
49.1) in comparison to low levels in the control C4 DRG (4.6% (-0.5-9.7) (Fig.4b, f). The 327 
numbers of cells expressing NF-200, IB4 or peripherin were unaltered in laminitic DRG 328 
compared to normal horses (696 compared to 575 NF-200-IR cells, n=32 sections, 115 329 
compared to 127 peripherin-IR cells, n=9 sections, 56 compared to 53 IB4-IR cells, n=5 330 
sections, in normal compared to laminitic horses, respectively). 331 
 332 
3.5. Laminitis is associated with a distinctive pattern of expression of Neuropeptide Y 333 
(NPY) in sensory neurons. 334 
A significant increase in NPY immunoreactivity (NPY-IR) was observed in the C8 DRG of 335 
laminitic horses, where 77% (17 sections, 271 cells, CI 72.0-82.3) of NF-200-positive cells 336 
showed NPY-IR co-localisation, compared to only 10% (17 sections, 351 cells CI 15.7-24.7) 337 
in control horses (χ21 = 193, p<0.001; Fig. 4).     338 
 339 
4. Discussion  340 
Damage to sensory nerves has been linked to abnormal pain and heightened sensitivity to 341 
touch in a variety of clinical and experimental studies. In this study, we have quantified for 342 
the first time abnormal behaviours associated with equine laminitis which are indicative of a 343 
hypersensitive sensory state. Additionally, we provide novel evidence for changes associated 344 
with nerve damage in the sensory nerves innnervating the forelimb in laminitic horses, which 345 
are consistent with those reported in previously characterised neuropathic pain states. 346 
 347 
4.1. The laminitic horses included in this study have digital pathology. 348 
Assessment of the radiographs from the laminitic horses identified pedal bone displacement 349 
(rotation or distal displacement) associated with laminar tearing. It was not possible to 350 
perform radiographic assessment of the control horses due to ethical and health and safety 351 
limitations, therefore data were compared to well established normal data (Cripps and 352 
Eustace, 1999). Chronic inflammatory changes were also observed (Fig. 1f, g) which have 353 
been previously shown to associate with sensory nerve losses in the skin (Lacomis et al., 354 
1997; Tseng et al., 2006). 355 
 356 
4.2. Laminitic horses display chronically altered behaviour.  357 
We have quantified two behavioural changes associated with laminitis, which are suggestive 358 
of a chronic hypersensitive neuropathic pain state, characterised by the development of 359 
allodynia, hyperalgesia and spontaneous pain. Forelimb lifting represents an abnormal, de 360 
novo behaviour associated with laminitis, being at low levels or absent in the clinically 361 
normal horse. The overall scores for frequency of forelimb lifting were significantly greater in 362 
laminitic than control horses. Additionally, laminitic horses spent more time positioned 363 
towards the back of the box, a retiring behaviour that has also been associated with acute 364 
post-surgical limb pain (Price et al, 2003). This behaviour may represent a reluctance to 365 
engage in the external environment and preference to remain withdrawn from surroundings.  366 
The differences in retiring behaviour (percentage of time spent at the back of the box) showed 367 
the appearance of a marked cyclical pattern, although this was not seen with forelimb lifting, 368 
weight bearing when walking or general demeanour. The pattern apparent in time at the back 369 
of the box observations may correspond to NSAID dosing times, external environmental 370 
stimuli or possibly an intrinsic diurnal rhythm. This emphasises the need for behavioural 371 
testing at a number of regular intervals in order to correctly reveal specific changes.  372 
Moreover, the consistent deviations from normal behaviour over the three-day period 373 
confirmed that the NSAID analgesic regime was not consistently effective. When individual 374 
time points were evaluated, marked differences from control horses were consistently seen at 375 
06:00h and 22:00h observations.   376 
 377 
4.3. Abnormal hoof sensory nerve morphology in laminitic horses is consistent with that 378 
reported in damaged peripheral nerves in neuropathic pain states. 379 
Two types of sensory receptor have been identified in the equine foot. Lamellated corpuscles, 380 
similar to Pacinian corpuscles, found primarily in the solar dermis of the heel, are low-381 
threshold mechanoreceptors, which transmit their input via rapidly conducting, myelinated A-382 
fibers (Bowker et al., 1993). Additionally, numerous naked nerve endings containing the 383 
neuropeptide, calcitonin gene related peptide (CGRP)-like immunoreactivity and other 384 
sensory neuropeptides such as substance P, neurokinin A and PHI (peptide histidine-385 
isoleucine) were detected in the dermis of the dorsal hoof wall and sole (Bowker et al., 1995). 386 
Those containing CGRP are associated with nociception (Schmidt, 1981) and transmit via 387 
slowly conducting C-fibers. Axons from the hoof nociceptors and low-threshold 388 
mechanoreceptors as well as sympathetic fibres innervating the vasculature contribute to the 389 
sensory digital nerve.  390 
Changes in any of these could potentially contribute to the etiology of the chronic laminitic 391 
pain state. To understand the mechanisms underlying laminitis pain and the incomplete 392 
response to anti-inflammatory analgesics, it is important to establish whether axonopathic 393 
changes may contribute. In laminitic horses, EM analysis identified marked decreases in 394 
myelinated and unmyelinated fiber numbers per unit area of digital nerve. This is unlikely to 395 
be due to nerve oedema as there were no significant differences between nerve section areas 396 
and fascicle areas in normal and laminitic horses. The marked increase in the number of 397 
solitary, unmyelinated fibers, may reflect demyelinated A-fibers, or an absence of guiding 398 
pathways for regenerating C-fibers (Bester et al., 1998).  These morphological changes are 399 
consistent with those in laboratory neuropathic pain models, such as chronic constriction 400 
injury (Gautron et al., 1990, Basbaum et al., 1991, Gabay and Tal, 2004; Micu et al., 2006), 401 
crush injury (Lozeron et al., 2004), photochemically-induced ischemia (Yu et al., 2000) and 402 
diabetic neuropathy (Sima et al., 1988; Llewelyn et al., 1991; Elias et al., 1998; Kalichman et 403 
al., 1998), thereby supporting our hypothesis that peripheral nerve damage may contribute to 404 
laminitis pain. 405 
 406 
Functional changes in the injured peripheral nerve have also been described in neuropathic 407 
pain models.  The loss of large fibers in nerves from laminitic horses is important as part of 408 
the behavioural changes in neuropathic pain states may result from the loss of spinal 409 
inhibitory controls exerted indirectly by these afferents (Basbaum et al., 1991). On the other 410 
hand, damage to both A and C-fibers appears to be necessary for the establishment of 411 
hyperalgesia and allodynia (Yu et al., 2000; Gabay and Tal, 2004). Electrophysiological 412 
studies further suggest that ectopic discharges in both spared C- and A-fibers may be 413 
important in maintaining neuropathic pain (Kajander and Bennett, 1992; Ali et al., 1999; 414 
Gabay and Tal, 2004).  415 
 416 
4.4. Sensory neurons of the forelimb in laminitic horses show characteristic changes 417 
associated with peripheral nerve injury  418 
Following peripheral nerve damage, phenotypic changes occur in primary sensory neurons 419 
that may contribute to mediating central sensitisation (Hokfelt et al., 1994; Tsujino et al., 420 
2000).  We assessed whether key neurochemical changes in sensory neurons of laminitic 421 
horses are similar to those in rodent neuropathic pain models. The numbers of DRG cells 422 
expressing anatomical markers NF-200, peripherin or IB4 were unaltered. Following nerve 423 
crush injury, peripherin increases transiently in large DRG cells (Wong and Oblinger, 1990). 424 
However, that model is associated with sensory loss (Bester et al., 1998) rather than the 425 
hypersensitivity seen here, as in other neuropathic and inflammatory pain states, where indeed 426 
peripherin expression is not upregulated (Facer et al., 2007, Renton et al., 2003, Rodriguez 427 
Parkitna et al., 2006). 428 
 429 
Neuronal expression of ATF3, which is normally minimal, is upregulated after peripheral 430 
nerve injury and so acts as a marker of nerve injury (Tsujino et al., 2000). The clear 431 
expression of ATF3 in NF-200, peripherin or IB4-positive sensory neurons of laminitic 432 
horses, indicates neuronal damage to both A and C-fibers matching our observations of 433 
abnormal nerve morphology. These findings suggest that primary afferent injury associated 434 
with laminitis arises locally from the damage caused by hoof pathology, rather than from 435 
systemic disease, since ATF3 expression is low in neurons of unaffected limbs. Ischemia and 436 
ischemia/reperfusion are established causes of ATF-3 expression (Hai et al., 1999), so the 437 
ischemia-reperfusion injury of the digit thought to underlie acute laminitis (Hood et al., 1993) 438 
may also be involved in neuronal damage. We also found upregulated expression of NPY in 439 
large NF-200-positive DRG cells from laminitic horses, paralleling observations in other 440 
neuropathic pain models (Wakisaka et al. 1991, 1992; Noguchi et al., 1993; Kashiba et al., 441 
1994; Nahin et al., 1994; Munglani et al., 1995; Rittenhouse et al., 1996; Ma and Bisby, 1998; 442 
Wallace et al., 2003).  443 
The novel findings reported here suggest that pathological changes occurring during laminitis 444 
bring about a chronic pain state with a neuropathic component. Although the mechanisms 445 
underlying the pathogenesis of laminitis remain to be fully elucidated, it is apparent that the 446 
early stages of laminitis are associated with vasoconstriction of the digital microvasculature 447 
(Peroni et al., 2006) and inflammation (Belknap et al., 2007). Indeed, such pathological 448 
events can result in nerve damage (e.g. Yu et al., 2000; Zimmermann, 2001; Moalem and 449 
Tracey, 2006) and may thereby play a part in laminitis pain through the transition from acute 450 
inflammatory pain to a chronic syndrome with a neuropathic pain component.  451 
Future studies will address the cellular and molecular mechanisms involved in the chronic 452 
laminitic pain state. These changes may be responsible, at least in part, for the limited efficacy 453 
of currently used anti-inflammatory therapy. The administration of anti-neuropathic agents 454 
may therefore achieve better pain management and improved quality of life in horses 455 
suffering from refractory laminitis. 456 
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 616 
 617 
 618 
 619 
 620 
Fig. 1. (a) Latero-medial radiograph of laminitic equine digit showing rotation and vertical 621 
displacement (“sinking”) of the third phalanx relative to normal anatomy. Lines represent the 622 
standardised methods for measuring displacement (D) which is the distance (mm) between the 623 
proximal limit of the dorsal hoof wall and the extensor process of the distal phalanx, and the 624 
rotation angle (α) which is the angle between the dorsal surface of the distal phalanx and the 625 
dorsal surface of hoof wall (Cripps and Eustace, 1999). (b) Haemotoxylin/Eosin (H&E) 626 
stained histological section of the intact lamellar distal phalangeal apparatus in a normal horse 627 
showing the normal appearance of dermal (arrowhead) and epidermal (arrow) laminae x10. 628 
(c) H&E stained histological section showing disruption and separation of the secondary 629 
epidermal (arrow) and secondary dermal (arrowhead) laminae in acute laminitis x10. (d) 630 
Chronic laminitis. Mild inflammation in the laminar dermis, with small foci of lymphocytes 631 
in a perivascular location (arrows). H&E, original magnification x20. (e) Chronic laminitis. 632 
Blood accumulation in the inner stratum medium. H&E, original magnification x 4. Scale bars 633 
(b-e) = 100 µm. 634 
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Fig. 2.  Quantifiable pain behaviours in laminitic horses compared to control horses. 658 
Behavioural indices were recorded in laminitic horses (▲, solid line) (n=7) and clinically 659 
normal (□, dashed line) horses (n=7) over a period of 3 days, with 1-hour observations at 660 
06:00 hrs, 14:00 hrs and 22:00 hrs. Phenylbutazone was administered each day at 08:00h and 661 
20:00h with supplementary acepromazine at 08:00h, 16:00h and 24:00h. (a) Forelimb lifting 662 
frequency adjusted for total time standing, expressed as lifts/min. When considering overall 663 
data, laminitic horses show a statistically significant increase in the mean square root 664 
frequency of forelimb lifting (± SE) adjusted for time spent standing compared to control 665 
horses recorded in the same environment over the same time period. (b) Proportion of time 666 
spent at the back of the box (away from the entrance), expressed as a percentage of time (± 667 
SE). Laminitic horses show a marked increase in the overall proportion of time spent at the 668 
back of the box, with marked differences from control horses at 06:00h and 22:00h. 669 
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Fig. 3. Reduced myelinated and unmyelinated fiber density associated with laminitis. (a)  695 
Electron microscopy images of digital nerve from a normal horse. Arrows indicate intact, 696 
normal myelinated fibers. Arrowheads indicate clustered unmyelinated fibers in Remak 697 
bundles. (b) Electron microscopy images of digital nerve from a laminitic horse displaying 698 
reduced myelinated fiber density (arrows), lower numbers of C-fibers per Remak bundle, as 699 
well as increased numbers of solitary fibers (arrowheads) and increased collagen-filled space, 700 
compared to normal horse. Scale bars, 5 µm. 701 
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Fig. 4. (a-e) Immunohistochemical co-localisation of DRG neuronal subtype markers (NF-732 
200 and peripherin, green) with neuronal injury marker, ATF3 or neuropeptide Y (NPY) (red) 733 
in C8 DRG (which receives forelimb innervation) of laminitic (a,d,e), or control horses (b) 734 
and co-localisation of NF-200 (green) with ATF3 (red) in C4 DRG (not associated with 735 
forelimb innervation) from the same horse  (c). (a) In laminitic horses, there was an increased 736 
expression of ATF3 (red) in NF-200-positive DRG cells (green) compared to C8 DRG control 737 
(non-laminitic) horse (b) and C4 DRG from laminitic horse (c). Laminitic horses show 738 
expression of ATF-3 (red) in peripherin-positive (green) in DRG cells (d), while control 739 
horses do not (data not shown). Additionally, there was increased co-localisation of NPY 740 
(red) and NF-200 (green) in C8 DRG cells of laminitic horses (e) compared to control horses, 741 
where there was normally only sparse NPY expression (data not shown). Scale bars, 100 µm. 742 
White arrows show co-localised immunopositive cells. Open arrows show cell marker (NF-743 
200 or peripherin)-positive cells lacking co-localisation. (f) Typical immunoblots of whole 744 
DRG lysates of laminitic horses (n=3), show clear ATF3 expression in C8 but not C4 DRG.  745 
Levels of the housekeeping enzyme, GAPDH (lower blots) were unchanged.  746 
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Table 1.  Details of horses used in the study. Sex abbreviations: MN –male, neutered; M- 775 
male, intact, F- female. Treatment abbreviations: PBZ – phenylbutazone; F – flunixin; A – 776 
aspirin, ACP – acepromazine; SS – solar supports; RF – remedial farriery; FT – foot 777 
trimming; NG – nitroglycerin (vasodilatory therapy); R – rehydration therapy; T – Trilostane 778 
(modifier of steroidogenesis); P – procaine penicillin + neomycin sulphate. 779 
Estimated weight range for laminitic horses: 250-550 kg; age range: 6-21 years. Control 780 
horses used were 3 females, 3 neutered male, and an intact male. Estimated weight range for 781 
control horses: 350-600 kg; age range: 8-19 years. 782 
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 786 
 787 
 788 
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 790 
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 792 
 793 
 794 
 795 
 796 
 797 
PBZ, RF None known: prior history 
unknown Recurrent  >1 year MN Laminitic 12 
PBZ, RF None known: prior history 
unknown Recurrent  >1 year MN Laminitic 11 
PBZ, FT None known: prior history 
unknown Recurrent  >1 year MN Laminitic 10 
PBZ, FT, RF Euthanasia requested for chronic 
condition Recurrent >1 year MN Laminitic 9 
PBZ, FT, ACP, NG, 
SS, RF, A None known: prior history unknown 1 month MN Laminitic 8 
PBZ, SS Access to rich pasture Recurrent  
>1 year MN Laminitic 7 
PBZ, RF, SS, NG, FT Obese Recurrent  
>1 year M Laminitic 6 
PBZ, F, SS, R, P Grain overload Recurrent  
>1 year MN Laminitic 5 
ACP, SS, F, A None known 2 days F Laminitic 4 
PBZ Obese Recurrent  
>1 year F Laminitic 3 
PBZ, ACP, RF, FT, SS Obese 2 months F Laminitic 2 
PBZ, ACP, NG, SS, 
RF, A, T Obese, increased liver enzymes 1 month MN Laminitic 1 
Prior treatments Possible 
precipitating/concurrent 
conditions 
Time 
from onset Sex Horse Group/No. 
Table 2.  Summary of myelinated and unmyelinated nerve fiber characteristics in normal and 798 
laminitic horses. Statistical significance is indicated by asterisks (* P value of <0.05, ** 799 
P<0.01, *** P<0.001; Linear mixed effects models, Mann Whitney test – Mean no. of fibers 800 
per 100 µm2-). Values are expressed as mean ±SEM. 801 
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834 
a)  Myelinated fibers 
 
1.09 (± 0.04) 1.06 (± 0.03) Mean thickness of myelin sheath (µm) 
5.08 (± 0.1) 5.38 (± 0.1)  Mean axon diameter (µm) 
72.46 (± 5.85) *** 17.45 (± 1.63) 
Mean percentage of A fibers with 
continuous (>40%) Schwann cell 
cytoplasm 
30.08 (± 5.67) *** 16.40 (± 2.75) Mean percentage of damaged A 
fibers  
0.34 (± 0.02) * 0.52 (± 0.04) Mean no. of fibers per 100 µm2 
Laminitic Horses 
n=5 
Normal Horses 
n=4 
Nerve fiber characteristics 
b) Unmyelinated fibers 
 
1.28 (± 0.01) 1.36 (± 0.01) Mean axon diameter (µm) 
38.06 (± 5.15) ***  30.14 (± 2.33)  Mean percentage of solitary 
unmyelinated fibers 
2.09 (± 0.03) ** 2.75 (± 0.07) Mean no. of fibers per Remak bundle 
3.28 (± 0.31) * 5.77 (± 0.53) Mean no. of fibers per 100µm2 
Laminitic Horses 
n=5 
Normal Horses 
n=4 
Nerve fiber characteristics 
Fig. 1. 835 
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Fig. 2. 838 
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Fig. 3. 841 
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Fig. 4. 892 
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